TLR9-mediated dendritic cell activation uncovers mammalian ganglioside species with specific ceramide backbones that activate invariant natural killer T cells
暂无分享,去创建一个
A. Speak | D. Priestman | F. Platt | R. Sandhoff | A. Futerman | C. Paget | F. Trottein | Y. Pewzner‐Jung | A. Saroha | S. Speca | Xiaobo Gu | D. Soulard | C. Faveeuw | T. Mallevaey | S. Deng | J. von Gerichten | Daphnée Soulard
[1] A. Merrill,et al. Critical Role for Very-Long Chain Sphingolipids in Invariant Natural Killer T Cell Development and Homeostasis , 2017, Front. Immunol..
[2] G. Besra,et al. University of Birmingham Structural determination of lipid antigens captured at the CD1d-T-cell receptor interface , 2017 .
[3] H. Gröne,et al. Diastereomer-specific quantification of bioactive hexosylceramides from bacteria and mammals[S] , 2017, Journal of Lipid Research.
[4] L. Fainboim,et al. The tumor antigen N-glycolyl-GM3 is a human CD1d ligand capable of mediating B cell and natural killer T cell interaction , 2016, Cancer Immunology, Immunotherapy.
[5] J. McCluskey,et al. The burgeoning family of unconventional T cells , 2015, Nature Immunology.
[6] D. Dombrowicz,et al. CD3bright signals on γδ T cells identify IL‐17A‐producing Vγ6Vδ1+ T cells , 2015, Immunology and cell biology.
[7] B. L. Anderson,et al. The identification of the endogenous ligands of natural killer T cells reveals the presence of mammalian α-linked glycosylceramides. , 2014, Immunity.
[8] F. Destaillats,et al. Longitudinal Evolution of the Concentration of Gangliosides GM3 and GD3 in Human Milk , 2014, Lipids.
[9] G. Besra,et al. Activation of iNKT cells by a distinct constituent of the endogenous glucosylceramide fraction , 2014, Proceedings of the National Academy of Sciences.
[10] D. Nixon,et al. Invariant natural killer T cells developing in the human fetus accumulate and mature in the small intestine , 2014, Mucosal Immunology.
[11] G. D’Angelo,et al. Glycosphingolipids: synthesis and functions , 2013, The FEBS journal.
[12] M. Fischbach,et al. Production of α-Galactosylceramide by a Prominent Member of the Human Gut Microbiota , 2013, PLoS biology.
[13] J. Rossjohn,et al. Natural Killer T cell obsession with self-antigens. , 2013, Current opinion in immunology.
[14] Jelena S. Bezbradica,et al. Role for lysosomal phospholipase A2 in iNKT cell-mediated CD1d recognition , 2013, Proceedings of the National Academy of Sciences.
[15] S. Balk,et al. Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production. , 2012, Immunity.
[16] Anneliese O. Speak,et al. Globosides but Not Isoglobosides Can Impact the Development of Invariant NKT Cells and Their Interaction with Dendritic Cells , 2012, The Journal of Immunology.
[17] J. Sirard,et al. Key role for respiratory CD103(+) dendritic cells, IFN-γ, and IL-17 in protection against Streptococcus pneumoniae infection in response to α-galactosylceramide. , 2012, The Journal of infectious diseases.
[18] C. Heuser,et al. Molecular identification of GD3 as a suppressor of the innate immune response in ovarian cancer. , 2012, Cancer research.
[19] R. Siebert,et al. Microbial Exposure During Early Life Has Persistent Effects on Natural Killer T Cell Function , 2012, Science.
[20] Vrajesh V. Parekh,et al. Activation of invariant natural killer T cells by lipid excess promotes tissue inflammation, insulin resistance, and hepatic steatosis in obese mice , 2012, Proceedings of the National Academy of Sciences.
[21] S. Sansano,et al. Peroxisome-derived lipids are self antigens that stimulate invariant natural killer T cells in the thymus , 2012, Nature Immunology.
[22] Y. Hannun,et al. Ceramide synthases at the centre of sphingolipid metabolism and biology. , 2012, The Biochemical journal.
[23] G. Besra,et al. Invariant natural killer T cells recognize lipid self-antigen induced by microbial danger signals , 2011, Nature Immunology.
[24] G. Besra,et al. Recognition of β-linked self glycolipids mediated by natural killer T cell antigen receptors , 2011, Nature Immunology.
[25] Dieter Braun,et al. Molecular interaction studies using microscale thermophoresis. , 2011, Assay and drug development technologies.
[26] P. Marrack,et al. A molecular basis for NKT cell recognition of CD1d-self-antigen. , 2011, Immunity.
[27] A. Futerman,et al. Mammalian ceramide synthases , 2010, IUBMB life.
[28] Liana C. Silva,et al. A Critical Role for Ceramide Synthase 2 in Liver Homeostasis , 2010, The Journal of Biological Chemistry.
[29] R. Dwek,et al. Activation state and intracellular trafficking contribute to the repertoire of endogenous glycosphingolipids presented by CD1d , 2010, Proceedings of the National Academy of Sciences.
[30] Wilfried Bardet,et al. Determination of Cellular Lipids Bound to Human CD1d Molecules , 2009, PloS one.
[31] L. Obeid,et al. Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate. , 2008, Biochimica et biophysica acta.
[32] D. Pellicci,et al. Humans Lack iGb3 Due to the Absence of Functional iGb3-Synthase: Implications for NKT Cell Development and Transplantation , 2008, PLoS biology.
[33] P. Chapman,et al. Fine specificity of natural killer T cells against GD3 ganglioside and identification of GM3 as an inhibitory natural killer T‐cell ligand , 2008, Immunology.
[34] Anneliese O. Speak,et al. Modulation of human natural killer T cell ligands on TLR-mediated antigen-presenting cell activation , 2007, Proceedings of the National Academy of Sciences.
[35] Michael B. Brenner,et al. CD1 antigen presentation: how it works , 2007, Nature Reviews Immunology.
[36] Anneliese O. Speak,et al. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. , 2007, Immunity.
[37] Anneliese O. Speak,et al. Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals , 2007, Proceedings of the National Academy of Sciences.
[38] Anneliese O. Speak,et al. Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency , 2007, Proceedings of the National Academy of Sciences.
[39] P. Cresswell,et al. Saposin B is the dominant saposin that facilitates lipid binding to human CD1d molecules , 2007, Proceedings of the National Academy of Sciences.
[40] Albert Bendelac,et al. The biology of NKT cells. , 2007, Annual review of immunology.
[41] A. Tonevitsky,et al. Bacterial infections promote T cell recognition of self-glycolipids. , 2005, Immunity.
[42] B. Beutler,et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections , 2005, Nature.
[43] G. Besra,et al. Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[44] R. Proia,et al. Lysosomal Glycosphingolipid Recognition by NKT Cells , 2004, Science.
[45] R. Dwek,et al. Analysis of fluorescently labeled glycosphingolipid-derived oligosaccharides following ceramide glycanase digestion and anthranilic acid labeling. , 2004, Analytical biochemistry.
[46] N. Segal,et al. Cross-presentation of Disialoganglioside GD3 to Natural Killer T Cells , 2003, The Journal of experimental medicine.
[47] R. Proia,et al. Enhanced insulin sensitivity in mice lacking ganglioside GM3 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[48] Seokmann Hong,et al. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. , 1997, Immunity.
[49] M. Kiso,et al. A synthetic approach to polysialogangliosides containing alpha-sialyl-(2-->8)-sialic acid: total synthesis of ganglioside GD3. , 1993, Carbohydrate research.
[50] Y. Ito,et al. Stereocontrolled synthesis of GD2. , 1993, Carbohydrate research.